The global home sleep apnea testing devices market size is calculated at USD 1,415.90 million in 2025 and is forecasted to reach around USD 5,554.30 million by 2034, accelerating at a CAGR of 16.44% from 2025 to 2034. The North America home sleep apnea testing devices market size surpassed USD 412.06 million in 2024 and is expanding at a CAGR of 16.50% during the forecast period. The market sizing and forecasts are revenue-based (USD Million/Billion), with 2024 as the base year.
1.1. Research Objective
1.2. Scope of the Study
1.3. Definition
2.1. Research Approach
2.2. Data Sources
2.3. Assumptions & Limitations
3.1. Market Snapshot
4.1. Introduction
4.2. Market Classification and Scope
4.3. Industry Value Chain Analysis
4.3.1. Raw Material Procurement Analysis
4.3.2. Sales and Distribution Channel Analysis
4.3.3. Downstream Buyer Analysis
5.1. COVID-19 Landscape: Home Sleep Apnea Testing Devices Industry Impact
5.2. COVID 19 - Impact Assessment for the Industry
5.3. COVID 19 Impact: Global Major Government Policy
5.4. Market Trends and Opportunities in the COVID-19 Landscape
6.1. Market Dynamics
6.1.1. Market Drivers
6.1.2. Market Restraints
6.1.3. Market Opportunities
6.2. Porter’s Five Forces Analysis
6.2.1. Bargaining power of suppliers
6.2.2. Bargaining power of buyers
6.2.3. Threat of substitute
6.2.4. Threat of new entrants
6.2.5. Degree of competition
7.1.1. Company Market Share/Positioning Analysis
7.1.2. Key Strategies Adopted by Players
7.1.3. Vendor Landscape
7.1.3.1. List of Suppliers
7.1.3.2. List of Buyers
8.1. Home Sleep Apnea Testing Devices Market Revenue and Volume, by Test Type
8.1.1. Type 2
8.1.1.1. Market Revenue and Volume Forecast
8.1.2. Type 3
8.1.2.1. Market Revenue and Volume Forecast
8.1.3. Type 4
8.1.3.1. Market Revenue and Volume Forecast
9.1. North America
9.1.1. Market Revenue and Volume Forecast, by Test Type
9.1.2. U.S.
9.1.2.1. Market Revenue and Volume Forecast, by Test Type
9.1.3. Rest of North America
9.1.3.1. Market Revenue and Volume Forecast, by Test Type
9.2. Europe
9.2.1. Market Revenue and Volume Forecast, by Test Type
9.2.2. UK
9.2.2.1. Market Revenue and Volume Forecast, by Test Type
9.2.3. Germany
9.2.3.1. Market Revenue and Volume Forecast, by Test Type
9.2.4. France
9.2.4.1. Market Revenue and Volume Forecast, by Test Type
9.2.5. Rest of Europe
9.2.5.1. Market Revenue and Volume Forecast, by Test Type
9.3. APAC
9.3.1. Market Revenue and Volume Forecast, by Test Type
9.3.2. India
9.3.2.1. Market Revenue and Volume Forecast, by Test Type
9.3.3. China
9.3.3.1. Market Revenue and Volume Forecast, by Test Type
9.3.4. Japan
9.3.4.1. Market Revenue and Volume Forecast, by Test Type
9.3.5. Rest of APAC
9.3.5.1. Market Revenue and Volume Forecast, by Test Type
9.4. MEA
9.4.1. Market Revenue and Volume Forecast, by Test Type
9.4.2. GCC
9.4.2.1. Market Revenue and Volume Forecast, by Test Type
9.4.3. North Africa
9.4.3.1. Market Revenue and Volume Forecast, by Test Type
9.4.4. South Africa
9.4.4.1. Market Revenue and Volume Forecast, by Test Type
9.4.5. Rest of MEA
9.4.5.1. Market Revenue and Volume Forecast, by Test Type
9.5. Latin America
9.5.1. Market Revenue and Volume Forecast, by Test Type
9.5.2. Brazil
9.5.2.1. Market Revenue and Volume Forecast, by Test Type
9.5.3. Rest of LATAM
9.5.3.1. Market Revenue and Volume Forecast, by Test Type
10.1. Fisher & Paykel Healthcare
10.1.1. Company Overview
10.1.2. Product Offerings
10.1.3. Financial Performance
10.1.4. Recent Initiatives
10.2. ImThera Medical, Inc.
10.2.1. Company Overview
10.2.2. Product Offerings
10.2.3. Financial Performance
10.2.4. Recent Initiatives
10.3. Natus Medical, Inc.
10.3.1. Company Overview
10.3.2. Product Offerings
10.3.3. Financial Performance
10.3.4. Recent Initiatives
10.4. Somnetics International, Inc.
10.4.1. Company Overview
10.4.2. Product Offerings
10.4.3. Financial Performance
10.4.4. Recent Initiatives
10.5. Braebon Medical Corporation
10.5.1. Company Overview
10.5.2. Product Offerings
10.5.3. Financial Performance
10.5.4. Recent Initiatives
10.6. BMC Medical Co., Ltd.
10.6.1. Company Overview
10.6.2. Product Offerings
10.6.3. Financial Performance
10.6.4. Recent Initiatives
10.7. Teleflex, Inc.
10.7.1. Company Overview
10.7.2. Product Offerings
10.7.3. Financial Performance
10.7.4. Recent Initiatives
10.8. Weinmann Medical Devices GmbH & Co., KG.
10.8.1. Company Overview
10.8.2. Product Offerings
10.8.3. Financial Performance
10.8.4. Recent Initiatives
10.9. Philips Respironics
10.9.1. Company Overview
10.9.2. Product Offerings
10.9.3. Financial Performance
10.9.4. Recent Initiatives
10.10. CareFusion Corp.
10.10.1. Company Overview
10.10.2. Product Offerings
10.10.3. Financial Performance
10.10.4. Recent Initiatives
11.1. Primary Research
11.2. Secondary Research
11.3. Assumptions
12.1. About Us
12.2. Glossary of Terms
For questions or customization requests, please reach out to us at sales@precedenceresearch.com
Plan your call and get expert insights!
Schedule a Meeting
No cookie-cutter, only authentic analysis – take the 1st step to become a Precedence Research client
Report Description
Get a Sample